{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:29:42Z","timestamp":1787761782008,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Treating primary hypothyroidism with appropriate weight-based dosing is usually straightforward. When supraphysiologic doses of thyroxine are required, it is important to know the reason behind the increased requirement. When compliance with medication is assured and when there are no drug interactions resulting in increased thyroxine requirements, a levothyroxine absorption test (LT4AT) could be performed to diagnose the coexistence of malabsorption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a single-center, retrospective chart review. Patients who had undergone LT4AT between 2018 and 2020 with a complete evaluation and follow-up records were reviewed. LT4AT and further evaluation (if necessary) were standardized, and details until the last review were obtained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In all, 11 patients had complete records and follow-up details. The median age (range) of the cohort was 24 years (19 to 46), and the duration of hypothyroidism was 8 years (4 to 24). Seven had low absorption (&lt;60%) in LT4AT of which two each had celiac disease and\n                      <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic>\n                      infection; one had autoimmune gastritis, and in two the reasons of malabsorption was not known. The median follow-up duration was 13 months. Nine of 11 (81%) achieved euthyroid state with\/without thyroxine dose reduction on follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A high proportion of patients requiring supraphysiological doses of levothyroxine had occult malabsorptive states, some of which were curable. Even in those with pseudo-malabsorption, LT4AT helped in reinforcing compliance and thereby thyroxine dose reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_188_21","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T04:58:18Z","timestamp":1677646698000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Levothyroxine Absorption Test \u2013 Results and Follow Up of Patients from a Single Center"],"prefix":"10.4103","volume":"27","author":[{"given":"Karthik","family":"Subramaniam","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Silverline Hospital, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Babu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Silverline Hospital, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Sreevalsan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Silverline Hospital, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemy","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Silverline Hospital, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/thy.1991.1.241","article-title":"Localization of human thyroxine absorption","volume":"1","author":"Hays","year":"1991","journal-title":"Thyroid"},{"key":"R2-20240828","first-page":"40","article-title":"A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism","volume":"9","author":"Colucci","year":"2013","journal-title":"Eur Endocrinol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/03007995.2018.1486293","article-title":"Adherence to thyroid hormone replacement therapy:A retrospective, claims database analysis","volume":"34","author":"Hepp","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000452489","article-title":"Pseudomalabsorption of levothyroxine:A challenge for the endocrinologist in the treatment of hypothyroidism","volume":"6","author":"Van Wilder","year":"2017","journal-title":"Eur Thyroid J"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/er.2018-00168","article-title":"Gastrointestinal malabsorption of thyroxine","volume":"40","author":"Virili","year":"2019","journal-title":"Endocr Rev"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9343(94)90093-0","article-title":"Sucralfate causes malabsorption of L-thyroxine","volume":"96","author":"Sherman","year":"1994","journal-title":"Am J Med"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4158\/EP13487.OR","article-title":"The clinical utility of free thyroxine in oral levothyroxine absorption testing","volume":"20","author":"Sun","year":"2014","journal-title":"Endocr Pract"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000504218","article-title":"Levothyroxine absorption test to differentiate pseudomalabsorption from true malabsorption","volume":"9","author":"Ghosh","year":"2020","journal-title":"Eur Thyroid J"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1089\/thy.2019.0256","article-title":"The levothyroxine absorption test:A four-year experience (2015-2018) at The Mayo Clinic","volume":"29","author":"Gonzales","year":"2019","journal-title":"Thyroid"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-12-1035","article-title":"A thyroxine absorption test followed by weekly thyroxine administration:A method to assess non-adherence to treatment","volume":"168","author":"Walker","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13044-015-0028-0","article-title":"A single bolus of high dose levothyroxine (L-T4) as a test in cases of suspected poor compliance to L-T4 therapy","volume":"8","author":"Lewandowski","year":"2015","journal-title":"Thyroid Res"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12020-019-01889-x","article-title":"Levothyroxine absorption test results in patients with TSH elevation resistant to treatment","volume":"64","author":"Yildirim Simsir","year":"2019","journal-title":"Endocrine"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/nu10070814","article-title":"Celiac disease and glandular autoimmunity","volume":"10","author":"Kahaly","year":"2018","journal-title":"Nutrients"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ajg.2015.398","article-title":"Prevalence of adult celiac disease in India:Regional variations and associations","volume":"111","author":"Ramakrishna","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jc.2005-1272","article-title":"Helicobacter pylori infection and autoimmune thyroid disease in young patients:The disadvantage of carrying the human leukocyte antigen-DRB1 *0301 allele","volume":"91","author":"Larizza","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1523-5378.2011.00830.x","article-title":"The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine","volume":"16","author":"Bugdaci","year":"2011","journal-title":"Helicobacter"},{"issue":"(8-S)","key":"R18-20240828","first-page":"100","article-title":"Autoimmune diseases in autoimmune atrophic gastritis","volume":"89","author":"Rodriguez-Castro","year":"2018","journal-title":"Acta Biomed"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2146\/ajhp120689","article-title":"Drug absorption in celiac disease","volume":"70","author":"Tran","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3748\/wjg.v24.i22.2373","article-title":"Treatment of Helicobacter pylori infection in atrophic gastritis","volume":"24","author":"Lahner","year":"2018","journal-title":"World J Gastroenterol"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_188_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:07:48Z","timestamp":1787760468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_188_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_188_21","relation":{},"ISSN":["2230-9500","2230-8210"],"issn-type":[{"value":"2230-9500","type":"print"},{"value":"2230-8210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"2021-05-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}